Fidson Healthcare PLC Pharmaceutical Import Profile — Nigeria (DGFT 2022–2026)

Name: Fidson Healthcare PLC Pharmaceutical Import Records from India — 7 Products, $8.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Fidson Healthcare PLC — Pharmaceutical Importer Profile (2026) | 7 Products, $8.3M Trade | TransData Nexus

Fidson Healthcare PLC

Pharmaceutical Importer · Nigeria · Antibiotics Focus · $8.3M Total Trade · DGFT Verified

Fidson Healthcare PLC is a pharmaceutical importer based in Nigeria with a total trade value of $8.3M across 7 products in 4 therapeutic categories. Based on 167 verified import shipments from Indian Customs (DGFT) records, Fidson Healthcare PLC is the #1 buyer in 2 products including Glucosamine, Chondroitin. Fidson Healthcare PLC sources from 11 verified Indian suppliers, with V S International Private Limited accounting for 35.6% of imports.

Fidson Healthcare PLC — Import Portfolio & Supplier Network

Fidson Healthcare PLC import network — 7 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Fidson Healthcare PLC?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
V S International Private Limited	$3.5M	114	35.6%
Medinomics Health Care Private Limited	$2.2M	68	22.7%
Granules India Limited

What Formulations Does Fidson Healthcare PLC Import?

Formulation	Value	Ships
Ciprotab 500-ciprofloxacin tablets USP	$250.0K	5
Arthocare forte (glucosamine, chondroitin and methyl sulphonyl methane with vitamin e & mineral tablets)	$244.6K	5
Fidson cefuroxime - 125 suspension	$233.2K	6
Ciprotab 500- ciprofloxacin tablets usp500 MG Pack	$208.1K	6
Ciprotab 500- ciprofloxacin tablets	$200.0K	4
E-mal INJ.(3x2ml) ceramic fidson	$200.0K	4
Panadol fd granulate	$200.0K	4
Astymin liquid 200ML - free	$150.0K	4
Arthocare forte caplets (glucosamine	$150.0K	3
Astyfer liquid 200ML - free	$150.0K	3
Ciprotab 500- ciprofloxacin tablets usp500 MG Pack: 1x10s	$150.0K	3
Ciprotab 500- ciprofloxacin tablets usp500 MG Pack	$144.7K	3
Ciprotab 500 - ciprofloxacin tablets usp500 MG ( Pack-1 x 14s)	$139.9K	3
Ciprotab 500 - ciprofloxacin tablets usp500 MG ( Pack-1 x 10s)	$137.6K	3
Ftdson cefuroxtme-125 suspension ( (cefuroxime 125MG/5ML-70ML plastic bottle	$130.7K	3

Fidson Healthcare PLC imports 248 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 7 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Ciprofloxacin	Antibiotics	$3.1M	63	1.0%	10
2	Ofloxacin	Advanced Antibiotics	$1.6M	33	0.6%	17
3	Glucosamine	Nutritional Supplements	$1.2M	24	9.1%	1
4	Cefuroxime	Advanced Antibiotics	$1.1M	21	0.8%	11
5	Chondroitin	Nutritional Supplements	$800.0K	16	15.7%	1
6	Tinidazole	Advanced Antibiotics	$288.9K	7	1.6%	8
7	Ayurvedic	Ayurvedic & Herbal Products	$150.0K	3	0.6%	19

Fidson Healthcare PLC imports 7 pharmaceutical products across 4 categories into Nigeria totaling $8.3M. The company is the #1 buyer for 2 products: Glucosamine, Chondroitin.

Fidson Healthcare PLC — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Fidson Healthcare PLC is a leading Nigerian pharmaceutical company specializing in the manufacturing, marketing, and distribution of a diverse range of healthcare products. Established in March 1995, the company has grown to become a prominent player in the West African healthcare sector. Headquartered at 268, Ikorodu Road, Obanikoro, Lagos, Nigeria, Fidson operates a state-of-the-art manufacturing facility in Ota, Ogun State, which is compliant with the World Health Organization's Current Good Manufacturing Practices (WHO-cGMP). This facility is among the few in Nigeria that are candidates for WHO prequalification.

Over the years, Fidson has expanded its product portfolio to include over 350 registered brands across various therapeutic classes, such as antibiotics, anti-malarial, anti-diabetic, and cardiovascular drugs. The company has also pioneered the local manufacturing of anti-retroviral (ARV) drugs, becoming the first in Sub-Saharan Africa to do so in March 2005. In 2008, Fidson was listed on the Nigerian Stock Exchange, marking a significant milestone in its growth trajectory.

2Distribution Network

Fidson Healthcare PLC has established an extensive distribution network to ensure the efficient delivery of its products across Nigeria. The company operates 11 strategically located depots in cities including Aba, Abuja, Akure, Enugu, Ibadan, Lagos, Jos, Kano, Onitsha, and Sokoto. This widespread presence enables Fidson to effectively serve a broad customer base, ensuring timely access to its pharmaceutical products nationwide.

3Industry Role

In Nigeria's pharmaceutical supply chain, Fidson Healthcare PLC functions primarily as a manufacturer and distributor. While the company imports certain finished pharmaceutical formulations, it also produces a significant portion of its product portfolio locally. This dual approach allows Fidson to maintain control over product quality and supply, ensuring a steady and reliable distribution of pharmaceuticals throughout Nigeria.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Fidson Healthcare PLC

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Fidson Healthcare PLC's import data indicates a high concentration in its sourcing strategy, with the top five imported products accounting for 94.7% of total imports from India. This concentration suggests a strategic focus on specific therapeutic areas, particularly in antibiotics and nutritional supplements. The company's reliance on a select group of suppliers, such as V S International Private Limited and Medinomics Health Care Private Limited, reflects a stable and potentially long-term relationship, which can lead to favorable terms and consistent product quality. However, this dependency also poses risks; any disruption in the supply chain from these key suppliers could significantly impact Fidson's operations. Diversifying the supplier base could mitigate such risks and enhance supply chain resilience.

2Supply Chain Resilience

Fidson Healthcare PLC's supply chain resilience is influenced by its sourcing strategy from India. The company's reliance on a limited number of suppliers for its top imported products indicates a potential vulnerability to supply disruptions. While the existing relationships with suppliers like V S International Private Limited and Medinomics Health Care Private Limited may offer stability, the lack of backup suppliers for these critical products could pose challenges in the event of unforeseen disruptions. Additionally, the concentration of shipments through specific ports and shipping routes exposes Fidson to logistical risks. To enhance resilience, Fidson could consider diversifying its supplier base and exploring alternative shipping routes, thereby reducing dependency on a few suppliers and logistical pathways.

Importing Pharmaceuticals into Nigeria — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Nigeria

1Regulatory Authority & Framework

In Nigeria, the National Agency for Food and Drug Administration and Control (NAFDAC) serves as the primary regulatory authority overseeing the importation, manufacturing, and distribution of pharmaceutical products. NAFDAC is responsible for ensuring that all pharmaceutical products meet the required safety, efficacy, and quality standards before they are marketed in Nigeria. The regulatory framework governing pharmaceutical imports includes compliance with NAFDAC's guidelines, which encompass product registration, labeling requirements, and adherence to Good Manufacturing Practices (GMP). For Indian pharmaceutical exporters, obtaining NAFDAC approval is a critical step in entering the Nigerian market, as it validates the product's compliance with local standards and facilitates smoother market access.

2Import Licensing & GMP

Import licensing in Nigeria requires that pharmaceutical products be registered with NAFDAC, which involves submitting detailed product information, including manufacturing processes, quality control measures, and clinical data. Recognition of Good Manufacturing Practice (GMP) certifications from reputable bodies such as the European Union (EU), World Health Organization (WHO), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S) is essential for the acceptance of imported pharmaceutical products. Indian exporters seeking to supply Fidson Healthcare PLC must ensure that their manufacturing facilities hold valid GMP certifications recognized by NAFDAC. Additionally, obtaining wholesale distribution authorization from NAFDAC is necessary to legally distribute pharmaceutical products within Nigeria.

Fidson Healthcare PLC — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Fidson Healthcare PLC's focus on importing specific therapeutic categories, particularly antibiotics and nutritional supplements, aligns with the prevalent health challenges in Nigeria, such as infectious diseases and nutritional deficiencies. The high import value of products like Ciprofloxacin, Ofloxacin, Glucosamine, Cefuroxime, and Chondroitin indicates a strategic emphasis on addressing these health issues. Market demand for effective treatments in these areas drives the imports, reflecting Fidson's commitment to meeting the healthcare needs of the Nigerian population.

2Sourcing Profile

Fidson Healthcare PLC's sourcing strategy involves importing finished pharmaceutical formulations from India, focusing on products that complement its local manufacturing capabilities. This approach allows Fidson to offer a comprehensive product portfolio while maintaining control over the quality and supply of its locally produced items. India's established pharmaceutical industry, recognized for its adherence to international GMP standards, makes it a reliable source for high-quality finished formulations.

3Market Positioning

Seller's Guide — How to Become a Supplier to Fidson Healthcare PLC

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Nigerian market by offering products that align with Fidson Healthcare PLC's strategic focus on antibiotics and nutritional supplements. Identifying gaps in Fidson's current sourcing, such as specific formulations or dosage forms not currently imported, could present avenues for collaboration. Establishing relationships with Fidson would require demonstrating compliance with NAFDAC's regulatory standards and a commitment to maintaining high-quality manufacturing practices.

2Requirements & Qualifications

Indian exporters aiming to supply Fidson Healthcare PLC and the Nigerian market must obtain NAFDAC registration for their products, ensuring compliance with local regulatory standards. Possessing GMP certifications recognized by NAFDAC, such as those from the EU, WHO, or PIC/S, is essential. Additionally, adherence to NAFDAC's labeling requirements and quality control measures is mandatory. Maintaining a consistent supply of high-quality products and demonstrating reliability in meeting demand are crucial for establishing a successful partnership.

3How to Approach

Frequently Asked Questions — Fidson Healthcare PLC

What products does Fidson Healthcare PLC import from India?

Fidson Healthcare PLC imports 7 pharmaceutical products across 4 categories. Top imports: Ciprofloxacin ($3.1M), Ofloxacin ($1.6M), Glucosamine ($1.2M), Cefuroxime ($1.1M), Chondroitin ($800.0K).

Who supplies pharmaceuticals to Fidson Healthcare PLC from India?

Fidson Healthcare PLC sources from 11 verified Indian suppliers. The primary supplier is V S International Private Limited (35.6% of imports, $3.5M).

What is Fidson Healthcare PLC's total pharmaceutical import value?

Fidson Healthcare PLC's total pharmaceutical import value from India is $8.3M, based on 167 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Fidson Healthcare PLC focus on?

Fidson Healthcare PLC imports across 4 categories. The largest: Antibiotics (38.0%), Advanced Antibiotics (36.1%), Nutritional Supplements (24.1%).

Get Full Fidson Healthcare PLC Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.